Lv3
248 积分 2024-02-01 加入
Quantification of febuxostat polymorphs using powder X-ray diffraction technique
17天前
已完结
The Effects of Polymorphism on Physicochemical Properties and Pharmacodynamics of Solid Drugs
2个月前
已完结
Pharmaceutical applications of Mid-IR and Raman spectroscopy
2个月前
已完结
Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients
2个月前
已完结
Applications of thermal analysis in the pharmaceutical industry
2个月前
已完结
Nanoparticles in the Pharmaceutical Industry and the Use of Supercritical Fluid Technologies for Nanoparticle Production
2个月前
已完结
Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH)
2个月前
已完结
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
2个月前
已完结
Resmetirom
2个月前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
